Abstract
Chronic protein depletion is mostly reflected in hypoproteinemia. All protein fractions can be reduced but a decreased serum albumin level, which forms the bulk of serum protein, is most prominent. This depressed serum albumin concentration can be the result of 1) an impaired synthesis; 2) an increased loss or degradation; 3) an altered distribution or 4) a combination of factors (1). Albumin has proved to be not essential to human life since patients with analbuminemia are without important symptoms (2). The functions of albumin are firstly to maintain plasma colloid osmotic pressure and secondly to bind and to transport several substances like metals, ions, fatty acids, drugs, hormones, bilirubin, metabolites, etc. (3). Hypoalbuminemia is not a disease in itself, but like for example a raised E.S.R., fever or weight loss, merely a symptom of a disease. Symptoms of a disease should only be treated if they are dangerous or troublesome to the patient. Obviously, the underlying disorder has to be treated as vigorously as possible. A favorable effect of such a treatment will often be reflected in increasing serum albumin levels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rothschild MA, Oratz M, Schreiber SS: Albumin metabolism. Gastroenterology 64: 324–337, 1973.
Waldmann TA, Gordon RS, Rosse W: Studies on the metabolism of the serum proteins and lipids in a patient with analbuminemia. Am J Med 37: 960–968, 1964.
Rosenoer VM: Clinical aspects of albumin metabolism. Albumin, structure, function and uses, Rosenoer VM, Oratz M, Rothschild MA (eds), Oxford-New York, Pergamon Press, 1977, pp 345–367.
Mayer K, Whitsett C: Albumin and plasma protein infusion in chronic protein deficiency or loss. Proceedings of the workshop on albumin, Feb. 12-13, 1975. Sgouris JT, René A, (eds), Publication no 76-925, National Institute of Health, Bethesda Md, pp 228–238.
Davison AM: The use of albumin concentrates in hypoproteinaemic states. Clinics in Haematology 5: 135–148, 1976.
Luetscher JA, Hall AD, Kremer VL. Treatment of nephrosis with concentrated human serum albumin. I. Effects on the proteins of body fluids. J Clin Invest 28: 700–712, 1949.
Luetscher JA, Hall AD, Kremer VL: Treatment of nephrosis with concentrated human serum albumin II. Effects on renal function and on excretion of water and some electrolytes. J Clin Invest 29: 896–904, 1950.
Davison AM, Lambie AT, Verth AH, et al: Salt-poor albumin in management of nephrotic syndrome. Br Med J 1: 481–484, 1974.
Losowsky MS, Atkinson M: Intravenous albumin in the treatment of diuretic-résistent ascites in portal cirrhosis. Lancet 2: 386–389, 1961.
Mankin H, Lowell A: Osmotic factors influencing the formation of ascites in patients with cirrhosis of the liver. J Clin Invest 27: 145–153, 1948.
Parbhoo SP, Ajdukiewicz A, Sherlock S: Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate. Lancet 1: 949–952, 1974.
Knauer CM, Lowe HM: Hemodynamics in the cirrhotic patient during paracentesis. N Engl J Med 276: 491–496, 1967.
Vlahcevic ZR, Adham NF, Chalmers TC, et al: Intravenous therapy of massive ascites in patients with cirrhosis. I. Short-term comparison with diuretic treatment. Gastroenterology 53: 211–219, 1967.
Shear L, Ching, S, Gabuzda GJ: Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 282: 1391–1396, 1970.
Le Veen HH, Wapnick S, Grosberg S, et al: Further experience with peritoneo-venous shunt for ascites. Ann Surg 184: 574–581, 1976.
Wilkinson P, Sherlock S: The effect of repeated albumin infusions in patients with cirrhosis. Lancet 2: 1125–1129, 1962.
Faloon WW, Eckhardt RD, Murphy TL, et al: An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 28: 583–594, 1949.
Van Tongeren JHM et al: Causes of hypoalbuminemia. This volume, p 117.
Yap SH, Hafkenscheid JCM, van Tongeren JHM, et al: Rate of synthesis of albumin in relation to serum levels of essential amino acids in patients with bacterial overgrowth in the small bowel. Eur J Clin Invest 4: 279–284, 1974.
Tullis JL: Albumin 2. Guidelines for clinical use. JAMA 237: 460–463, 1977.
Eknoyan G, Martinez-Maldonado M, Yium JJ, et al: Combined ascitic-fluid and furosemide infusion in the management of ascites. N Engl J Med 282: 713–717, 1970.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Martinus Nijhoff Publishers bv, The Hague.
About this chapter
Cite this chapter
Lamers, C.B.H.W. (1978). Use and abuse of albumin and plasma protein infusions in chronic protein depletion. In: Yap, S.H., Majoor, C.L.H., van Tongeren, J.H.M. (eds) Clinical Aspects of Albumin. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9744-8_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-9744-8_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-9746-2
Online ISBN: 978-94-009-9744-8
eBook Packages: Springer Book Archive